Logo Logo
[höher] Eine Ebene höher
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel | Konferenzbeitrag
Anzahl der Publikationen: 44

Zeitschriftenartikel

Kaiser, Lena; Quach, S.; Zounek, A. J.; Wiestler, B.; Zatcepin, A.; Holzgreve, A.; Bollenbacher, A.; Bartos, L. M.; Ruf, V. C.; Boening, G.; Thon, N.; Herms, J.; Riemenschneider, M. J.; Stoecklein, S.; Brendel, M.; Rupprecht, R.; Tonn, J. C.; Bartenstein, P.; von Baumgarten, L.; Ziegler, S. und Albert, N. L. (2024): Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET. In: European Journal of Nuclear Medicine and Molecular Imaging [PDF, 1MB]

Öcal, Osman; Schinner, Regina; Schütte, Kerstin; de Toni, Enrico N.; Loewe, Christian; Delden, Otto van; Vandecaveye, Vincent; Gebauer, Bernhard; Zech, Christoph J.; Sengel, Christian; Bargellini, Irene; Gasbarrini, Antonio; Sangro, Bruno; Pech, Maciej; Malfertheiner, Peter; Ricke, Jens; Seidensticker, Max; Kettner, E.; Amthauer, H.; Cwikla, J.; Walecki, J.; Klümpen, H.; Schott, E.; Kolligs, F.; Rosmorduc, O.; Menu, Y.; Leroy, V.; Mayerle, J.; Trumm, C.; Bartenstein, P.; Reiser, M.; Berg, T.; Moche, M.; Bilbao, I.; Gossner, L.; Reimer, P.; Popovic, P.; Stabuc, B.; Piasecki, P.; Podgajny, Z.; Sacco, R.; Peck-Radosavljevic, M.; Lammer, J.; Maleux, G.; Verslype, C.; Rosenberg, C.; Nitsche, D.; Waldenberger, P.; Vergniol, J.; Cassinotto, C.; Yalcin, S.; Peynircioglu, B.; Zavaglia, C.; Rampoldi, A.; Tran, A.; Chevallier, P.; Anty, R.; Trautwein, C.; Kuhl, C.; Grazioli, L.; Vogl, T.; Trojan, J.; Bartolozzi, C.; Iezzi, R.; Bronowicki, J. P.; Palmer, D.; Evans, J.; Sharma, R.; Weir, G.; Hubner, R.; Basu, B. und Ross, P. (4. Dezember 2022): Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib. In: Cancer Imaging, Bd. 22 [PDF, 955kB]

Bitzer, M.; Voesch, S.; Albert, J.; Bartenstein, P.; Bechstein, W.; Bloedt, S.; Brunner, T.; Dombrowski, F.; Evert, M.; Follmann, M.; La Fougere, C.; Freudenberger, P.; Geier, A.; Gkika, E.; Goetz, M.; Hammes, E.; Helmberger, T.; Hoffmann, R. T.; Hofmann, W. P.; Huppert, P.; Kautz, A.; Knoetgen, G.; Koerber, J.; Krug, D.; Lammert, F.; Lang, H.; Langer, T.; Lenz, P.; Mahnken, A.; Meining, A.; Micke, O.; Nadalin, S.; Nguyen, H. P.; Ockenga, J.; Oldhafer, K.; Paprottka, P.; Paradies, K.; Pereira, P.; Persigehl, T.; Plauth, M.; Plentz, R.; Pohl, J.; Riemer, J.; Reimer, P.; Ringwald, J.; Ritterbusch, U.; Roeb, E.; Schellhaas, B.; Schirmacher, P.; Schmid, I.; Schuler, A.; Schweinitz, D. von; Seehofer, D.; Sinn, M.; Stein, A.; Stengel, A.; Steubesand, N.; Stoll, C.; Tannapfel, A.; Taubert, A.; Trojan, J.; Thiel, I. van; Tholen, R.; Vogel, A.; Vogl, T.; Vorwerk, H.; Wacker, F.; Waidmann, O.; Wedemeyer, H.; Wege, H.; Wildner, D.; Wittekind, C.; Woerns, M. A.; Galle, P. und Malek, N. (2022): S3-Leitlinie – Diagnostik und Therapie biliärer Karzinome. Langversion 2.0 – Juni 2021 – AWMF-Registernummer: 032-053OL. In: Zeitschrift für Gastroenterologie, Bd. 60, Nr. 2, E186-E227

Bitzer, M.; Voesch, S.; Albert, J.; Bartenstein, P.; Bechstein, W.; Bloedt, S.; Brunner, T.; Dombrowski, F.; Evert, M.; Follmann, M.; La Fougere, C.; Freudenberger, P.; Geier, A.; Gkika, E.; Goetz, M.; Hammes, E.; Helmberger, T.; Hoffmann, R. T.; Hofmann, W. P.; Huppert, P.; Kautz, A.; Knoetgen, G.; Koerber, J.; Krug, D.; Lammert, F.; Lang, H.; Langer, T.; Lenz, P.; Mahnken, A.; Meining, A.; Micke, O.; Nadalin, S.; Nguyen, H. P.; Ockenga, J.; Oldhafer, K.; Paprottka, P.; Paradies, K.; Pereira, P.; Persigehl, T.; Plauth, M.; Plentz, R.; Pohl, J.; Riemer, J.; Reimer, P.; Ringwald, J.; Ritterbusch, U.; Roeb, E.; Schellhaas, B.; Schirmacher, P.; Schmid, I.; Schuler, A.; Schweinitz, D. von; Seehofer, D.; Sinn, M.; Stein, A.; Stengel, A.; Steubesand, N.; Stoll, C.; Tannapfel, A.; Taubert, A.; Trojan, J.; Thiel, I. van; Tholen, R.; Vogel, A.; Vogl, T.; Vorwerk, H.; Wacker, F.; Waidmann, O.; Wedemeyer, H.; Wege, H.; Wildner, D.; Wittekind, C.; Woerns, M. A.; Galle, P. und Malek, N. (2022): S3-Leitlinie: Diagnostik und Therapie biliärer Karzinome. Kurzversion 2.00 – Juni 2021, AWMF-Registernummer: 032-053OL. In: Zeitschrift für Gastroenterologie, Bd. 60, Nr. 2: S. 219-238

Spitzweg, C.; Nelson, P. J.; Wagner, E.; Bartenstein, P.; Weber, W. A.; Schwaiger, M. und Morris, J. C. (2021): The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment. In: Endocrine-Related Cancer, Bd. 28, Nr. 10: T193-T213

Gosewisch, Astrid; Schleske, M.; Gildehaus, F. J.; Berg, I.; Kaiser, L.; Brosch, J.; Bartenstein, P.; Todica, A.; Ilhan, Harun und Böning, G. (2021): Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT. In: European journal of nuclear medicine and molecular imaging, Bd. 48, Nr. 4: S. 1260-1261 [PDF, 303kB]

Unterrainer, M.; Eze, C.; Ilhan, H.; Marschner, S.; Roengvoraphoj, O.; Schmidt-Hegemann, N. S.; Walter, F.; Kunz, W. G.; Munck af Rosenschold, P.; Jeraj, R.; Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624; Grosu, A. L.; Niyazi, M.; Bartenstein, P. und Belka, C. (2020): Recent advances of PET imaging in clinical radiation oncology. In: Radiation Oncology, Bd. 15, Nr. 1, 88

Schmidt-Hegemann, N-S; Kroeze, S. G. C.; Henkenberens, C.; Vogel, M. M. E.; Kirste, S.; Becker, J.; Burger, I. A.; Derlin, T.; Bartenstein, P.; Eiber, M.; Mix, M.; la Fougere, Ch; Müller, A. C.; Grosu, A. L.; Combs, S. E.; Christiansen, H.; Guckenberger, M. und Belka, C. (2020): Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 47, Nr. 8: S. 1852-1863

Ilhan, Harun; Lindner, S.; Todica, A.; Cyran, C. C.; Tiling, R.; Auernhammer, C. J.; Spitzweg, C.; Boeck, S.; Unterrainer, M.; Gildehaus, F. J.; Böning, G.; Jurkschat, K.; Wängler, C.; Wängler, B.; Schirrmacher, R. und Bartenstein, P. (2020): Biodistribution and first clinical results of F-18-SiFAlin-TATE PET: a novel F-18-labeled somatostatin analog for imaging of neuroendocrine tumors. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 47, Nr. 4: S. 870-880

Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624; Unterrainer, M.; Kaiser, L.; Brendel, M.; Vettermann, F. J.; Holzgreve, A. und Bartenstein, P. (2020): In response to: Anatomy of 18F-GE180, a failed radioligand for the TSPO protein. In: European journal of nuclear medicine and molecular imaging, Bd. 47, Nr. 10: S. 2237-2241 [PDF, 975kB]

Mittlmeier, Lena M.; Unterrainer, Marcus; Rodler, S.; Todica, A.; Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624; Burgard, C.; Cyran, C. C.; Kunz, W. G.; Ricke, J.; Bartenstein, P.; Stief, C. G.; Ilhan, H. und Staehler, Michael (2020): 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results. In: European journal of nuclear medicine and molecular imaging [PDF, 2MB]

Unterrainer, Marcus; Fleischmann, D. F.; Diekmann, C.; Vomacka, L.; Lindner, S.; Vettermann, F.; Brendel, M.; Wenter, V.; Ertl-Wagner, B.; Herms, J.; Wetzel, C.; Rupprecht, R.; Tonn, J. C.; Belka, C.; Bartenstein, P.; Niyazi, M. und Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 (2019): Comparison of F-18-GE-180 and dynamic F-18-FET PET in high grade glioma: a double-tracer pilot study. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 46, Nr. 3: S. 580-590

Unterrainer, M.; Niyazi, M.; Tonn, J. C.; Ilhan, H.; Bartenstein, P. und Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 (2019): A look ahead: future directions of SSR-directed imaging and therapy in meningioma. In: Clinical and Translational Imaging, Bd. 7, Nr. 5: S. 357-362

Rudisile, S.; Gosewisch, A.; Wenter, V; Unterrainer, M.; Boening, G.; Gildehaus, F. J.; Fendler, W. P.; Auernhammer, C. J.; Spitzweg, C.; Bartenstein, P.; Todica, A. und Ilhan, H. (2019): Salvage PRRT with Lu-177-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival. In: BMC Cancer, Bd. 19, Nr. 1, 788

Unterrainer, M.; Niyazi, M.; Tonn, J. C.; Ilhan, H.; Bartenstein, P. und Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 (2019): Current status of SSR-directed imaging and therapy in meningioma. In: Clinical and Translational Imaging, Bd. 7, Nr. 3: S. 171-180

Kurch, L.; Hasenclever, D.; Kluge, R.; Georgi, T.; Tchavdarova, L.; Golombeck, M.; Sabri, O.; Eggert, A.; Brenner, W.; Sykora, K. W.; Bengel, F. M.; Rossig, C.; Koerholz, D.; Schäfers, M.; Feuchtinger, T.; Bartenstein, P.; Ammann, R. A.; Krause, T.; Urban, C.; Aigner, R.; Gattenloehner, S.; Klapper, W. und Mauz-Koerholz, C. (2019): Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET >= 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial. In: Pediatric Blood & Cancer, Bd. 66, Nr. 3, e27539

Fiedler, L.; Kellner, M.; Gosewisch, A.; Oos, R.; Boening, G.; Lindner, S.; Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624; Bartenstein, P.; Reulen, H.-J.; Zeidler, R. und Gildehaus, F. J. (2018): Evaluation of Lu-177[Lu]-CHX-A ''-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII. In: Nuclear Medicine and Biology, Bd. 60: S. 55-62

Unterrainer, M.; Winkelmann, I.; Suchorska, B.; Giese, A.; Wenter, V.; Kreth, F. W.; Herms, J.; Bartenstein, P.; Tonn, J. C. und Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 (2018): Biological tumour volumes of gliomas in early and standard 20-40 min F-18-FET PET images differ according to IDH mutation status. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 7: S. 1242-1249

Unterrainer, Marcus; Mahler, C.; Vomacka, L.; Lindner, S.; Havla, J.; Brendel, M.; Böning, G.; Ertl-Wagner, B.; Kümpfel, T.; Milenkovic, V. M.; Rupprecht, R.; Kerschensteiner, M.; Bartenstein, P. und Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 (2018): TSPO PET with [F-18]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 8: S. 1423-1431

Hegemann, N.-S.; Fendler, W. P.; Bartenstein, P.; Eze, C.; Herlemann, A.; Buchner, A.; Gratzke, C.; Stief, C.; Li, M.; Ballhausen, H.; Belka, C. und Ganswindt, U. (2017): Early efficacy of Ga-68-PSMA PET/CT based radiotherapy in patients with biochemical failure or persistence after radical prostatectomy. In: Strahlentherapie und Onkologie, Bd. 193: S65-S65

Hegemann, N.-S.; Fendler, W. P.; Bartenstein, P.; Eze, C.; Herlemann, A.; Buchner, A.; Gratzke, C.; Stief, C.; Li, M.; Ballhausen, H.; Belka, C. und Ganswindt, U. (2017): Pattern and extent of nodal relapse diagnosed with PSMA PET/CT in patients with biochemical failure or persistence after radical prostatectomy. In: Strahlentherapie und Onkologie, Bd. 193: S17-S17

Vettermann, F. J.; Neumann, J. E.; Suchorska, B.; Bartenstein, P.; Giese, A.; Dorostkar, M. M.; Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 und Schüller, U. (2017): K27M midline gliomas display malignant progression by imaging and histology. In: Neuropathology and Applied Neurobiology, Bd. 43, Nr. 5: S. 458-462

Schönecker, S.; Prix, C.; Raiser, T.; Ackl, N.; Wlasich, E.; Stenglein-Krapf, G.; Mille, E.; Brendel, M.; Sabri, O.; Patt, M.; Barthel, H.; Bartenstein, P.; Levin, J.; Rominger, A. und Danek, A. (2017): Amyloid-Positronenemissionstomographie mit [18 F]-Florbetaben in der Demenzdiagnostik. In: Nervenarzt, Bd. 88, Nr. 2: S. 156-161

Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624; Unterrainer, M.; Fleischmann, D. F.; Lindner, S.; Vettermann, F.; Brunegraf, A.; Vomacka, L.; Brendel, M.; Wenter, V.; Wetzel, C.; Rupprecht, R.; Tonn, J.-C.; Belka, C.; Bartenstein, P. und Niyazi, M. (2017): TSPO PET for glioma imaging using the novel ligand F-18-GE-180: first results in patients with glioblastoma. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 44, Nr. 13: S. 2230-2238

Eilles, E.; Guenther, L.; Xiong, G.; Oos, R.; Zwergal, A.; Bartenstein, P. und Beck, R. (2016): Differential cerebral plasticity after bilateral audio-vestibular damage in a rat model: A comparative [F-18] FDG-mu PET behavioral analysis. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43: S99-S99

Weiss, M.; Siegert, S.; Bartenstein, P. und Rominger, A. (2016): Metastatic mammary carcinoma despite histologically negative sentinel lymph nodes: are there any indicators for estimating recurrence and metastasis rates? In: European Journal of Gynaecological Oncology, Bd. 37, Nr. 6: S. 820-826

Barthel, H.; Jovalekic, A.; Bullich, S.; DeSanti, S.; Koglin, N.; Stephens, A.; Dresel, S.; Bartenstein, P.; Seibyl, J. und Sabri, O. (2016): Scan time-windows and diagnostic performance of florbetaben amyloid PET imaging. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43: S118-S119

Delker, A.; Gosewisch, A.; Rieger, S.; Ilhan, H.; Fendler, W.; Gildehaus, F.; Bartenstein, P. und Boening, G. (2016): Dosimetry for Lu-177-PSMA therapy of patients with mCRPC: A comparison of 3D SPECT and 2D planar methods. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43: S213-S214

Lindner, S.; Rensch, C.; Neubaur, S.; Neumeier, M.; Salvamoser, R.; Samper, V. und Bartenstein, P. (2016): Azeotropic drying free [F-18]FDG synthesis and its application to a lab-on-chip platform. In: Chemical Communications, Bd. 52, Nr. 4: S. 729-732

Hartenbach, M.; Weber, S.; Hartenbach, S.; Zacherl, M.; Papprottka, P. M.; Tiling, R.; Bartenstein, P.; Hacker, M.; Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 und Haug, A. (2016): Prognoctic value of combined [(99m)]Tc-MAA-SPECT/CT and [F-18]Fluorethylcholine-PET/CT in patients suffering from advanced hepatocellular carcinoma prior to radioembolization. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43: S17-S17

Rominger, A.; Brendel, M.; Schonecker, S.; Hoeglinger, G.; Lindner, S.; Danek, A.; Levin, J.; Bartenstein, P. und Okamura, N. (2016): 18F-THK5351 PET in Patients with Clinically Diagnosed PSP. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43: S132-S132

Vomacka, L.; Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624; Mille, E.; Suchorska, B.; Unterrainer, M.; Gosewisch, A.; Bartenstein, P. und Boening, G. (2016): 3D analysis of glioma heterogeneity with pseudo-kinetic and pharmacokinetic model parameters in dynamic 18F-FET PET. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43: S194-S194

Vomacka, L.; Delker, A.; Gosewisch, A.; Fendler, W.; Gildehaus, F.; Brunegraf, A.; Bartenstein, P. und Boening, G. (2016): Automatic image segmentation for efficient 3D dosimetry with reduced influence of registration-errors and noise in Lu-177 DKFZ-PSMA-617 therapy using a robust cluster algorithm on sequential SPECT data and subsequent voxel-wise re-scaling. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43: S36-S36

Gosewisch, A.; Delker, A.; Tattenberg, S.; Vomacka, L.; Gildehaus, F. J.; Brunegraf, A.; Bartenstein, P. und Boening, G. (2016): Investigation of a hybrid image approach and a reduction in the number of blood samples for a decreased clinical workload for patient-specific bone marrow dosimetry in Lu-177-DKFZ-PSMA-617 therapy. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43: S415-S415

Michl, M.; Haug, A. R.; Jakobs, T. F.; Paprottka, Philipp M.; Hoffmann, R.-T.; Bartenstein, P.; Boeck, S.; Haas, M.; Laubender, R. P. und Heinemann, V. (2014): Radioembolization with Yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: Efficacy, safety and prognostic factors. In: Oncology, Bd. 86, Nr. 1: S. 24-32 [PDF, 265kB]

Michl, M.; Haug, A. R.; Jakobs, T. F.; Paprottka, P.; Hoffmann, R. T.; Bartenstein, P.; Boeck, S.; Haas, M.; Laubender, Rüdiger P. und Heinemann, V. (2014): Radioembolization with Yttrium-90 Microspheres (SIRT) in Pancreatic Cancer Patients with Liver Metastases: Efficacy, Safety and Prognostic Factors. In: Oncology, Bd. 86, Nr. 1: S. 24-32

Übleis, Christopher; Hoyer, X.; van Kriekinge, S. D.; Schuessler, F.; Laubender, Rüdiger P.; Becker, A.; Lehner, S.; Todica, A.; Haug, A.; Bartenstein, P.; Cumming, P.; Germano, G. und Hacker, M. (2013): Association between left ventricular mechanical dyssynchrony with myocardial perfusion and functional parameters in patients with left bundle branch block. In: Journal of Nuclear Cardiology, Bd. 20, Nr. 2: S. 253-261

Übleis, Christopher; Hellweger, S.; Laubender, Rüdiger P.; Becker, A.; Sohn, H. Y.; Lehner, S.; Haug, A.; Bartenstein, P.; Cumming, P.; van Kriekinge, S. D.; Slomka, P. J. und Hacker, M. (2013): The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction. In: International Journal of Cardiovascular Imaging, Bd. 29, Nr. 7: S. 1645-1653

Übleis, Christopher; Hellweger, S.; Laubender, Rüdiger P.; Becker, A.; Sohn, H. Y.; Lehner, S.; Haug, A.; Bartenstein, P.; Cumming, P.; van Kriekinge, S. D.; Slomka, P. J. und Hacker, M. (2012): Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapy. In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 39, Nr. 10: S. 1561-1569

Übleis, Christopher; Becker, A.; Griesshammer, I.; Cumming, P.; Becker, C.; Schmidt, M.; Bartenstein, P. und Hacker, M. (2009): Stable coronary artery disease: prognostic value of myocardial perfusion SPECT in relation to coronary calcium scoring‐long-term follow-up. In: Radiology, Bd. 252, Nr. 3: S. 682-690

Bokde, ALW; Teipel, S. J.; Drzezga, A.; Thissen, J.; Bartenstein, P.; Dong, W.; Leinsinger, G.; Born, C.; Schwaiger, Markus; Möller, Hans-Jürgen und Hampel, H. (2005): Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease. In: Dementia and Geriatric Cognitive Disorders, Nr. 6: S. 352-357 [PDF, 90kB]

Preuss, Ulrich W.; Bahlmann, Miriam; Bartenstein, P.; Schütz, Christian G. und Soyka, Michael (2001): Memantine treatment in alcohol dementia: Rapid PET changes and clinical course. In: European Neurology, Nr. 1: S. 57-58 [PDF, 220kB]

Konferenzbeitrag

Zwergal, A.; Günther, L.; Brendel, M.; Eilles, E.; Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624; La Fougere, C.; Ziegler, S.; Bartenstein, P.; Becker-Bense, S.; Brandt, T. und Dieterich, M. (2017): Glial activation accelerates compensation of acute unilateral vestibulopathy. [Oral session O2235]. 3rd Congress of the European Academy of Neurology, Amsterdam, The Netherlands, June 2017. European Journal of Neurology. Bd. 24, Nr. S1 Wiley. S. 81

Brendel, M.; Jaworska, A.; Lindner, S.; Gildehaus, F.; Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624; Beck, R.; Bartenstein, P.; Herms, J.; Kleinberger, G.; Haass, C. und Rominger, A. (2016): Microglia, Amyloidosis and TREM2 Progress in Parallel during the Life Course of PS2APP Mice. EANM '16, 29th Annual Congress of the European Association of Nuclear Medicine, Barcelona, Spain, October 15–19, 2016. European Journal of Nuclear Medicine and Molecular Imaging. Bd. 43, Nr. S1 Springer. S100-S100

Diese Liste wurde am Sat Nov 23 20:28:20 2024 CET erstellt.

Open Access LMU verwendet EPrints 3, das an der School of Electronics and Computer Science der Universität Southampton entwickelt wurde.
Impressum − Datenschutz